Hospital acquired infections (HAIs) have become a global menace adding to morbidity, mortality and cost associated with hospital based healthcare. The incidence of antibiotic resistant infections is on the rise perhaps due to indiscriminate use of antibiotics. This adds a tremendous burden to national economy, but can be effectively prevented. In one study, the overall annual direct medical costs associated with HAI, to U.S.
Hospitals, ranged from $35.7 billion to $45 billion. The benefit of various infection control interventions, ranged from $5.7 to $31.5 billion, for inpatient hospital services. According to a 2014 article, the most common type of HAI reported in US hospitals is Clostridium difficile (C. Diff) infections, followed by surgical site infections (SSIs), catheter-associated urinary tract infections (CAUTIs), methicillin-resistant Staphylococcus aureus (MRSA) bloodstream…
